The In Silico Clinical Trials Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Better Understanding of the Safety Aspects of the Drug and Increasing Initiatives Projected to Boost Industry Growth
The in silico clinical trials market is experiencing remarkable growth, largely fueled by two key driving factors. Firstly, the efficiency in rapidly evaluating the safety and efficacy of medical products through virtual patient cohorts and simulations is a prominent catalyst for the growth of the market. By mimicking illness and treatment scenarios, these methods efficiently pinpoint safety concerns and provide valuable insights into product effectiveness. Pharmaceutical companies are drawn to this approach due to its ability to expedite the acquisition of crucial safety and efficacy data required for regulatory approvals.
Secondly, the burgeoning support and recognition from regulatory bodies like the FDA and EMA are significantly boosting the adoption of in silico clinical trials. Major players in the pharmaceutical industry are embracing this approach and presenting in silico evidence to regulators, showcasing the quality, safety, and efficacy of their medical products. This regulatory backing underscores the increasing importance of in silico trials and amplifies their role in the drug development process, acting as a strong impetus for market growth.
Furthermore, collaborative endeavors such as eTRANSAFE, aimed at developing and sharing in silico tools for safety assessment, further contribute to the momentum of the market. The robust evidence that in silico trials provide for drug safety and efficacy is reshaping pharmaceutical and medical device development, positioning in silico clinical trial as a pivotal and rapidly expanding domain within the broader healthcare industry landscape.
Lack of Comprehensive Datasets and Unavailability of Advanced Testing Facilities Likely to Challenge Industry Growth
The growth of the in silico clinical trials market is constrained by several significant restraining factors. Firstly, the unavailability of advanced testing facilities and infrastructure poses challenges for research groups and companies, particularly those with limited resources. Building and maintaining the required infrastructure for in silico clinical trials, involving hardware, software, and personnel training, presents a financial hurdle. Secondly, the lack of comprehensive datasets hampers the development of robust in silico models. Access to high-quality datasets is crucial for accurate modelling, but privacy concerns, proprietary data issues, and data harmonization challenges limit data availability and sharing.
Overall, the unavailability of advanced infrastructure and comprehensive datasets collectively act as restraining factors that hinder the growth of the in silico clinical trials market, impacting both resource-constrained organizations and the overall advancement of the field.
What Questions Should You Ask before Buying a Market Research Report?
• How is the In Silico Clinical Trials Market evolving?
• What is driving and restraining the In Silico Clinical Trials Market?
• How will each In Silico Clinical Trials submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each In Silico Clinical Trials submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading In Silico Clinical Trials Market broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the In Silico Clinical Trials Market projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of In Silico Clinical Trials Market projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the In Silico Clinical Trials Market?
• Where is the In Silico Clinical Trials Market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the In Silico Clinical Trials Market today, and over the next 10 years:
• Our 230+ page report provides 98 tables and 133 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the In Silico Clinical Trials Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising popularity of In Silico Clinical Trials and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
By Application
• Drug Development
• Medical Device Development
By End-users
• Pharmaceutical & Biotechnology Companies
• Contract Research Organisations
• Others
By Therapeutic Area
• Oncology
• Infectious Disease
• Cardiology
• Neurology
• Other Therapeutic Areas
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the In Silico Clinical Trials Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Abzena Ltd.
• Acellera Ltd.
• Aitia
• Allucent
• Certara
• Clarivate
• Dassault Systemes
• Evotec SE
• Immunetrics
• Insilico Medicine
• InSilicoTrials Technologies
• Novadiscovery
Overall global revenue for In Silico Clinical Trials Market, 2023 to 2033 in terms of value the market will surpass US$3,000 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the In Silico Clinical Trials Market, 2023 to 2033 report help you?
In summary, our 230+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for In Silico Clinical Trials Market, 2023 to 2033 Market, with forecasts for Application, End-users, and Therapeutic Area each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 21 key national markets – See forecasts for the In Silico Clinical Trials Market, 2023 to 2033 in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 12 of the major companies involved in the In Silico Clinical Trials Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the In Silico Clinical Trials Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today In Silico Clinical Trials Market Report 2023-2033: Forecasts by Application (Drug Development, Medical Device Development), by End-users (Pharmaceutical & Biotechnology Companies, Contract Research Organisations, Others), by Therapeutic Area (Oncology, Infectious Disease, Cardiology, Neurology, Other Therapeutic Areas) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to In Silico Clinical Trials Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Better Understanding of the Safety Aspects of the Drug
3.2.1.2 Cost Saving and Time Efficiency
3.2.1.3 Increasing Initiatives and Growing Acceptance from Several Organisations
3.2.2 Market Restraining Factors
3.2.2.1 Lack of Comprehensive Datasets
3.2.2.2 Results Derived From Estimations or Approximation
3.2.2.3 Unavailability of Advanced Testing Facilities and Infrastructure
3.2.3 Market Opportunities
3.2.3.1 Expanded Therapeutic Areas
3.2.3.2 Rising Product Approvals with Associated Collaboration and Partnerships
3.2.3.3 Adoption and Integration of Clinical Trials
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 In Silico Clinical Trials Market Analysis by Application
4.1 Key Findings
4.2 Application Segment: Market Attractiveness Index
4.3 In Silico Clinical Trials Market Size Estimation and Forecast by Application
4.4 Drug Development
4.4.1 Drug Development: Market Attractiveness Index
4.4.1.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.1.2 Market Share by Region, 2023 & 2033 (%)
4.4.2 Preclinical and Early Stage
4.4.2.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.2.2 Market Share by Region, 2023 & 2033 (%)
4.4.3 Phase I
4.4.3.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.3.2 Market Share by Region, 2023 & 2033 (%)
4.4.4 Other Stages
4.4.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Medical Device Development
4.5.1.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.1.2 Market Share by Region, 2023 & 2033 (%)
5 In Silico Clinical Trials Market Analysis by End-users
5.1 Key Findings
5.2 End-users Segment: Market Attractiveness Index
5.3 In Silico Clinical Trials Market Size Estimation and Forecast by End-users
5.4 Pharmaceutical & Biotechnological Companies
5.4.1.1 Market Size by Region, 2023-2033 (US$ Million)
5.4.1.2 Market Share by Region, 2023 & 2033 (%)
5.5 Contract Research Organisations
5.5.1.1 Market Size by Region, 2023-2033 (US$ Million)
5.5.1.2 Market Share by Region, 2023 & 2033 (%)
5.6 Others
5.6.1.1 Market Size by Region, 2023-2033 (US$ Million)
5.6.1.2 Market Share by Region, 2023 & 2033 (%)
6 In Silico Clinical Trials Market Analysis by Therapeutic Area
6.1 Key Findings
6.2 Therapeutic Area Segment: Market Attractiveness Index
6.3 In Silico Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
6.4 Oncology
6.4.1.1 Market Size by Region, 2023-2033 (US$ Million)
6.4.1.2 Market Share by Region, 2023 & 2033 (%)
6.5 Infection Diseases
6.5.1.1 Market Size by Region, 2023-2033 (US$ Million)
6.5.1.2 Market Share by Region, 2023 & 2033 (%)
6.6 Cardiology
6.6.1.1 Market Size by Region, 2023-2033 (US$ Million)
6.6.1.2 Market Share by Region, 2023 & 2033 (%)
6.7 Neurology
6.7.1.1 Market Size by Region, 2023-2033 (US$ Million)
6.7.1.2 Market Share by Region, 2023 & 2033 (%)
6.8 Other Therapeutic Areas
6.8.1.1 Market Size by Region, 2023-2033 (US$ Million)
6.8.1.2 Market Share by Region, 2023 & 2033 (%)
7 In Silico Clinical Trials Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
8 North America In Silico Clinical Trials Market Analysis
8.1 Key Findings
8.2 North America In Silico Clinical Trials Market Attractiveness Index
8.3 North America In Silico Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
8.4 North America In Silico Clinical Trials Market Size Estimation and Forecast by Country
8.5 North America In Silico Clinical Trials Market Size Estimation and Forecast by Application
8.6 North America In Silico Clinical Trials Market Size Estimation and Forecast by End-users
8.7 North America In Silico Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
8.8 U.S. In Silico Clinical Trials Market Analysis
8.9 Canada In Silico Clinical Trials Market Analysis
9 Europe In Silico Clinical Trials Market Analysis
9.1 Key Findings
9.2 Europe In Silico Clinical Trials Market Attractiveness Index
9.3 Europe In Silico Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 Europe In Silico Clinical Trials Market Size Estimation and Forecast by Country
9.5 Europe In Silico Clinical Trials Market Size Estimation and Forecast by Application
9.6 Europe In Silico Clinical Trials Market Size Estimation and Forecast by End-users
9.7 Europe In Silico Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
9.8 Germany In Silico Clinical Trials Market Analysis
9.9 France In Silico Clinical Trials Market
9.10 UK In Silico Clinical Trials Market Analysis
9.11 Italy In Silico Clinical Trials Market Analysis
9.12 Spain In Silico Clinical Trials Market Analysis
9.13 Rest of Europe In Silico Clinical Trials Market Analysis
10 Asia Pacific In Silico Clinical Trials Market Analysis
10.1 Key Findings
10.2 Asia Pacific In Silico Clinical Trials Market Attractiveness Index
10.3 Asia Pacific In Silico Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Asia Pacific In Silico Clinical Trials Market Size Estimation and Forecast by Country
10.5 Asia Pacific In Silico Clinical Trials Market Size Estimation and Forecast by Application
10.6 Asia Pacific In Silico Clinical Trials Market Size Estimation and Forecast by End-users
10.7 Asia Pacific In Silico Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
10.8 Japan In Silico Clinical Trials Market Analysis
10.9 China In Silico Clinical Trials Market Analysis
10.10 India In Silico Clinical Trials Market Analysis
10.11 Australia In Silico Clinical Trials Market Analysis
10.12 South Korea In Silico Clinical Trials Market Analysis
10.13 Rest of Asia Pacific In Silico Clinical Trials Market Analysis
11 Latin America In Silico Clinical Trials Market Analysis
11.1 Key Findings
11.2 Latin America In Silico Clinical Trials Market Attractiveness Index
11.3 Latin America In Silico Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Latin America In Silico Clinical Trials Market Size Estimation and Forecast by Country
11.5 Latin America In Silico Clinical Trials Market Size Estimation and Forecast by Application
11.6 Latin America In Silico Clinical Trials Market Size Estimation and Forecast by End-users
11.7 Latin America In Silico Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
11.8 Brazil In Silico Clinical Trials Market Analysis
11.9 Mexico In Silico Clinical Trials Market Analysis
11.10 Argentina In Silico Clinical Trials Market Analysis
11.11 Rest of Latin America In Silico Clinical Trials Market Analysis
12 MEA In Silico Clinical Trials Market Analysis
12.1 Key Findings
12.2 MEA In Silico Clinical Trials Market Attractiveness Index
12.3 MEA In Silico Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 MEA In Silico Clinical Trials Market Size Estimation and Forecast by Country
12.5 MEA In Silico Clinical Trials Market Size Estimation and Forecast by Application
12.6 MEA In Silico Clinical Trials Market Size Estimation and Forecast by End-users
12.7 MEA In Silico Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
12.8 GCC In Silico Clinical Trials Market Analysis
12.9 South Africa In Silico Clinical Trials Market Analysis
12.10 Rest of MEA In Silico Clinical Trials Market Analysis
13 Company Profiles
13.1 Competitive Landscape, 2022
13.2 Strategic Outlook
13.3 Novadiscovery
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Product Benchmarking
13.3.4 Strategic Outlook
13.4 Insilico Medicine
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Product Benchmarking
13.4.4 Strategic Outlook
13.5 Dassault Systemes
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2017-2022
13.5.3.2 R&D, 2017-2022
13.5.3.3 Regional Market Shares, 2022
13.5.3.4 Segment Market Shares, 2022
13.5.4 Product Benchmarking
13.5.5 Strategic Outlook
13.6 Aitia
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.6.4 Strategic Outlook
13.7 Immunetrics
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Product Benchmarking
13.8 Certara
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2018-2022
13.8.3.2 R&D, 2018-2022
13.8.3.3 Segment Market Shares, 2022
13.8.4 Product Benchmarking
13.8.5 Strategic Outlook
13.9 Clarivate
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2017-2022
13.9.3.2 Regional Market Shares, 2022
13.9.4 Product Benchmarking
13.9.5 Strategic Outlook
13.10 Evotec SE
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis Financial Analysis
13.10.3.1 Net Revenue, 2017-2022
13.10.3.2 R&D, 2017-2022
13.10.4 Product Benchmarking
13.10.5 Strategic Outlook
13.11 Abzena Ltd
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
13.11.4 Strategic Outlook
13.12 InSilicoTrials Technologies
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Product Benchmarking
13.12.4 Strategic Outlook
13.13 Acellera Ltd.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Product Benchmarking
13.13.4 Strategic Outlook
13.14 Allucent
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Product Benchmarking
13.14.4 Strategic Outlook
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
List of Tables
Table 1 In Silico Clinical Trials Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 In Silico Clinical Trials Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 3 In Silico Clinical Trials Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 4 In Silico Clinical Trials Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 5 In Silico Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 6 Drug Development Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 7 Preclinical and Early Stage Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 8 Phase I Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 9 Other Stages (Phase II, Phase III) Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 10 Medical Device Development Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 11 In Silico Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 13 Contract Research Organisations Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 14 Others Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 15 In Silico Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 17 Infectious Disease Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 18 Cardiology Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 19 Neurology Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 20 Other Therapeutic Areas Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 21 In Silico Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 North America In Silico Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 North America In Silico Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 North America In Silico Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 North America In Silico Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 U.S. In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Canada In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Europe In Silico Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 Europe In Silico Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 Europe In Silico Clinical Trials Market Forecast by Equipment, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 Europe In Silico Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 Germany In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 France In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 UK In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Italy In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Spain In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Rest of Europe In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Asia-Pacific In Silico Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Asia Pacific In Silico Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Asia Pacific In Silico Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Asia Pacific In Silico Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Japan In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 China In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 India In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Australia In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 South Korea In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Rest of Asia Pacific In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Latin America In Silico Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Latin America In Silico Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Latin America In Silico Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Latin America In Silico Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Brazil In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Mexico In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Argentina In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 Rest of Latin America In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 MEA In Silico Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 MEA In Silico Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 MEA In Silico Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 MEA In Silico Clinical Trials Market Forecast by Equipment, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 GCC In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 South Africa In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Rest of MEA In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Strategic Outlook
Table 64 Novadiscovery: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 65 Novadiscovery: Product Benchmarking
Table 66 Novadiscovery: Strategic Outlook
Table 67 Insilico Medicine: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 68 Insilico Medicine: Product Benchmarking
Table 69 Insilico Medicine: Strategic Outlook
Table 70 Dassault Systemes: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 71 Dassault Systemes: Product Benchmarking
Table 72 Dassault Systemes: Strategic Outlook
Table 73 Aitia: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Aitia: Product Benchmarking
Table 75 Aitia: Strategic Outlook
Table 76 Immunetrics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Immunetrics.: Product Benchmarking
Table 78 Certara: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Certara: Product Benchmarking
Table 80 Certara: Strategic Outlook
Table 81 Clarivate: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Clarivate: Product Benchmarking
Table 83 Clarivate: Strategic Outlook
Table 84 Evotec SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Evotec SE: Product Benchmarking
Table 86 Evotec SE: Strategic Outlook
Table 87 Abenza Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Abzena Ltd: Product Benchmarking
Table 89 Abzena Ltd: Strategic Outlook
Table 90 InSilicoTrials Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 InSilicoTrial Technologies: Product Benchmarking
Table 92 InSilicoTrial Technologies: Strategic Outlook
Table 93 Acellera Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Acellera Ltd.: Product Benchmarking
Table 95 Acellera Ltd.: Strategic Outlook
Table 96 Allucent: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Acellera LTD: Product Benchmarking
Table 98 Acellera LTD: Strategic Outlook
List of Figures
Figure 1 In Silico Clinical Trials Market Segmentation
Figure 2 In Silico Clinical Trials Market by Application: Market Attractiveness Index
Figure 3 In Silico Clinical Trials Market by Drug Development: Market Attractiveness Index
Figure 4 In Silico Clinical Trials Market by End Users: Market Attractiveness Index
Figure 5 In Silico Clinical Trials Market by Therapeutic Area: Market Attractiveness Index
Figure 6 In Silico Clinical Trials Market Attractiveness Index by Region
Figure 7 In Silico Clinical Trials Market: Market Dynamics
Figure 8 In Silico Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 9 In Silico Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 10 In Silico Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 11 In Silico Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 12 In Silico Clinical Trials Market: Porter’s Five Forces Analysis
Figure 13 In Silico Clinical Trials Market: Porter’s Five Forces Analysis
Figure 14 In Silico Clinical Trials Market by Application: Market Attractiveness Index
Figure 15 In Silico Clinical Trials Market Share Forecast by Application, 2023, 2028, 2033 (%)
Figure 16 In Silico Clinical Trials Market by Application: Market Attractiveness Index
Figure 17 Drug Development Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Drug Development Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Preclinical and Early Stage Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Preclinical and Early Stage Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Phase I Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 22 Phase I Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Other Stages Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 24 Other Stages Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Medical Device Development Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 26 Medical Device Development Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 In Silico Clinical Trials Market by End-users: Market Attractiveness Index
Figure 28 In Silico Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 29 In Silico Clinical Trials Market Share Forecast by Product Type, 2023, 2028, 2033 (%)
Figure 30 Pharmaceutical and Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 31 Pharmaceutical and Biotechnology Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Contract Research Organisations Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Contract Research Organisations Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Other End-users Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 35 Other End-users Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 In Silico Clinical Trials Market by Therapeutic Area: Market Attractiveness Index
Figure 37 In Silico Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 38 In Silico Clinical Trials Market Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
Figure 39 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Infectious Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 Infectious Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Cardiology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 44 Cardiology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Neurology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 46 Neurology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Other Therapeutic Areas Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 48 Other Therapeutic Areas Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 In Silico Clinical Trials Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 50 In Silico Clinical Trials Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 51 In Silico Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 52 North America In Silico Clinical Trials Market Attractiveness Index
Figure 53 North America In Silico Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 54 North America In Silico Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 55 North America In Silico Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 56 North America In Silico Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 57 North America In Silico Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 58 North America In Silico Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 59 North America In Silico Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 60 North America In Silico Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 61 North America In Silico Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 62 U.S. In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 63 Canada In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 64 Europe In Silico Clinical Trials Market Attractiveness Index
Figure 65 Europe In Silico Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 66 Europe In Silico Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 67 Europe In Silico Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 68 Europe In Silico Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 69 Europe In Silico Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 70 Europe In Silico Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 71 Europe In Silico Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 72 Europe In Silico Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 73 Europe In Silico Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 74 Germany In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 75 France In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 76 UK In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 77 Italy In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 78 Spain In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 79 Rest of Europe In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 80 Asia Pacific In Silico Clinical Trials Market Attractiveness Index
Figure 81 Asia Pacific In Silico Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 82 Asia Pacific In Silico Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 83 Asia Pacific In Silico Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 84 Asia Pacific In Silico Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 85 Asia Pacific In Silico Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 86 Asia Pacific In Silico Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 87 Asia Pacific In Silico Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 88 Asia Pacific In Silico Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 89 Asia Pacific In Silico Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 90 Japan In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 91 China In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 92 India In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 93 Australia In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 94 South Korea In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 95 Rest of Asia Pacific In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 96 Latin America In Silico Clinical Trials Market Attractiveness Index
Figure 97 Latin America In Silico Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 98 Latin America In Silico Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 99 Latin America In Silico Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 100 Latin America In Silico Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 101 Latin America In Silico Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 102 Latin America In Silico Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 103 Latin America In Silico Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 104 Latin America In Silico Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 105 Latin America In Silico Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 106 Brazil In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 Mexico In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 108 Argentina In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 109 Rest of Latin America In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 110 MEA In Silico Clinical Trials Market Attractiveness Index
Figure 111 MEA In Silico Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 112 MEA In Silico Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 113 MEA In Silico Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 114 MEA In Silico Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 115 MEA In Silico Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 116 MEA In Silico Clinical Trials Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 117 MEA In Silico Clinical Trials Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 118 MEA In Silico Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 119 MEA In Silico Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 120 GCC In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 121 South Africa In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 122 Rest of MEA In Silico Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 123 Dassault Systemes: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 124 Dassault Systemes: R&D, 2017-2022 (US$ Million, AGR%)
Figure 125 Dassault Systemes: Regional Market Shares, 2022
Figure 126 Dassault Systemes: Regional Market Shares, 2022
Figure 127 Certara: Net Revenue, 2018-2022 (US$ Thousand, AGR%)
Figure 128 Certara: R&D, 2018-2022 (US$ Thousand, AGR%)
Figure 129 Certara: Segment Market Shares, 2022
Figure 130 Clarivate: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 131 Clarivate: Regional Market Shares, 2022
Figure 132 Evotec SE.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 133 Evotec SE.: R&D, 2017-2022 (US$ Million, AGR%)
List of Companies Profiled in the Report
Abzena Ltd.
Acellera Ltd.
Aitia
Allucent
Certara
Clarivate
Dassault Systemes
Evotec SE
Immunetrics
Insilico Medicine
InSilicoTrials Technologies
Novadiscovery
List of Other Companies Mentioned in the Report
Astellas Pharma Inc.
Exploristics
In Silico World
Pfizer, Inc.
Premier Research
QuantHealth
RxCelerate
Sanofi
Shionogi & Co. Ltd.
Veritas In-silico Inc.
WuXi AppTec
List of Associations Mentioned in the Report
Association of Clinical Research Organizations (ACRO)
Association of Clinical Research Professionals (ACRP)
Association of the British Pharmaceutical Industry (ABPI)
China Pharmaceutical Innovation and Research Development Association (PhIRDA)
Clinical Data Interchange Standards Consortium (CDISC)
Clinical Research Forum (CR Forum)
Clinical Trials Ontario (CTO)
Clinical Trials Transformation Initiative (CTTI)
Drug Information Association (DIA)
European Clinical Research Infrastructures Network (ECRIN)
Indian Society for Clinical Research (ISCR)
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Japan Pharmaceutical Manufacturers Association (JPMA)
National Institute for Health Research (NIHR)
Pharmaceutical Research and Manufacturers of America (PhRMA)
Society for Clinical Data Management (SCDM)
Society for Clinical Trials (SCT)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
